In the following years, the report notes, it is planned to significantly increase the production of the drug. The technological features of the production of this product allow it to be released into civilian circulation in a short time, the department added. “To create BioGam, our holding used its own patented technology. It involves additional methods of protein purification, inactivation and removal of viruses,” the State Corporation specified.
Immunoglobulin is used to alleviate the condition of people with impaired immunity, in particular, it helps to more effectively resist viruses, bacteria and toxins. The introduction of the drug increases the level of antibodies in the blood and reduces the risk of infection.